IP Library Assignment 070438/0333
Patent Assignment
Reel/Frame 070438/0333

Release of First Lien Security Interest in Patents

Recorded: 2025-03-06 Pages: 7
Assignor
ROYAL BANK OF CANADA
Executed: 2025-03-06
Assignees
CAMBREX CHARLES CITY, INC.
ONE MEADOWLANDS PLAZA, EAST RUTHERFORD, NEW JERSEY, 07073
AVISTA PHARMA SOLUTIONS, INC.
ONE MEADOWLANDS PLAZA, EAST RUTHERFORD, NEW JERSEY, 07073
SNAPDRAGON CHEMISTRY, INC.
ONE MEADOWLANDS PLAZA, EAST RUTHERFORD, NEW JERSEY, 07073
Covered Properties (34)
Nicotine-Containing, Controlled Release Composition and Method
Patent: 6,586,449 →
Application: 10/166,236 →
Nicotine-Containing, Controlled Release Composition and Method
Patent: 6,828,336 →
Application: 10/429,420 →
Publication: US 2003/0224048
Process for Preparing Anhydrous Aripirazole Type I
Patent: 8,039,621 →
Application: 12/445,771 →
Publication: US 2010/0317857
Method of Making Amphetamine
Patent: 7,705,184 →
Application: 12/466,457 →
Publication: US 2009/0292143
Method of Making Piperidine Derivatives
Patent: 8,299,258 →
Application: 12/612,089 →
Publication: US 2010/0137604
Methods and Compositions for Preparing Lisdexamfetamine and Salts Thereof
Patent: 8,779,191 →
Application: 12/973,453 →
Publication: US 2012/0157706
Methods and Compositions for Preparation of Amphetamine Conjugates and Salts Thereof
Patent: 8,614,346 →
Application: 13/378,176 →
Publication: US 2012/0190880
Preparation of Saturated Ketone Morphinan Compounds by Catalytic Isomerisation
Patent: 9,981,978 →
Application: 14/906,776 →
Publication: US 2016/0168159
Antiparasitic Compounds
Patent: 9,420,793 →
Application: 14/995,547 →
Publication: US 2016/0205936
Antiparasitic Compounds
Patent: 9,643,963 →
Application: 15/036,335 →
Publication: US 2016/0280700
Antiparasitic Compounds
Patent: 9,686,991 →
Application: 15/211,062 →
Publication: US 2016/0324156
Antiparasitic Compounds
Application: 15/477,343 →
Publication: US 2017/0202849
Process for the Formation of Hydrocodone Bitatrate
Patent: 9,981,979 →
Application: 15/523,054 →
Publication: US 2017/0327511
Antiparasitic Compounds
Patent: 9,883,674 →
Application: 15/603,556 →
Publication: US 2017/0258089
New Process for Preparing Hydromorphone and Derivatives Thereof
Application: 15/747,980 →
Publication: US 2018/0354961
Antiparasitic Compounds
Application: 15/849,834 →
Publication: US 2018/0116223
A COMPOUND 1-[2-[4-(2-ETHYL-6,8-DIMETHYLIMIDAZO[1,2-a]PYRAZIN-3-YL)PHENYL]ETHYL]-3-(p-TOLYLSULFONYL)UREA AS A PROSTAGLANDIN EP4 RECEPTOR ANTAGONIST
Application: 16/100,315 →
Antiparasitic Compounds
Application: 16/123,251 →
Publication: US 2019/0000085
Single Enantiomer Antiparasitic Compounds
Application: 16/192,103 →
Publication: US 2019/0152983
Substituted Ureas as Prostaglandin EP4 Receptor Antagonists
Application: 16/263,518 →
Publication: US 2019/0382404
Synthetic Process and Intermediates
Application: 16/302,944 →
Publication: US 2019/0284199
Antiparasitic Compounds
Application: 16/315,778 →
Publication: US 2020/0181134
Antiparasitic Compounds
Application: 16/420,627 →
Publication: US 2019/0274305
Continuous Flow Photoreactor
Application: 16/986,503 →
Publication: US 2021/0039063
Automated Online Chromatographic Sample Dilution & Preparation System
Application: 17/340,264 →
Publication: US 2021/0382023
Antiparasitic Compounds
Application: 62/160,188 →
Synthetic Process and Novel Intermediates
Application: 62/339,136 →
Antiparasitic Compounds
Application: 62/359,719 →
Synthetic Process and Novel Intermediates
Application: 62/491,337 →
Single Enantiomer Antiparasitic Compounds
Application: 62/587,132 →
Chemical Compounds
Application: 62/686,299 →
Chemical Compounds
Application: 62/755,679 →
Synthetic Process and Novel Intermediates
Application: 62/798,735 →
Chemical Compounds
Application: 62/798,738 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name Jul 20, 2006
From: SALSBURY CHEMICALS, INC
To: CAMBREX CHARLES CITY, INC
Reel/Frame 017957/0905 →
Assignment of Assignor's Interest Apr 19, 2011
From: BAUER, MICHAEL J.; CALLEN, GARY RICHARD; HUMPHREY, JUDI CHRISTINE; JOHNSON, TODD JEFFREY
To: CAMBREX CHARLES CITY, INC.
Reel/Frame 026148/0179 →
Assignment of Assignor's Interest Apr 12, 2016
From: TRACEY, MICHAEL; HOLMBERG, PÄR
To: CAMBREX CHARLES CITY, INC.
Reel/Frame 038249/0545 →
Assignment of Assignor's Interest Apr 15, 2016
From: SPEAKE, JASON D.; PERALES, JOE B.; FAN, WEIMING; ROLLAND, SOLENE CLARISSE
To: AVISTA PHARMA SOLUTIONS
Reel/Frame 038295/0329 →
Assignment of Assignor's Interest Nov 8, 2016
From: SPEAKE, JASON D; PERALES, JOE B; FAN, WEIMING; ROLLAND, SOLENE CLARISSE
To: AVISTA PHARMA SOLUTIONS
Reel/Frame 040254/0363 →
Assignment of Assignor's Interest Dec 9, 2016
From: MATUTE, BELÉN LINDBERG MARTIN; GÓMEZ, ANTONIO BERMEJO; BÄCKVALL, JAN-ERLING
To: STOCKHOLMS UNIVERSITET HOLDING AB OF STOCKHOLM UNIVERSITY
Reel/Frame 040699/0975 →
Assignment of Assignor's Interest Dec 12, 2016
From: STOCKHOLMS UNIVERSITET HOLDING AB OF STOCKHOLM UNIVERSITY
To: CAMBREX KARLSKOGA AB
Reel/Frame 040708/0988 →
Assignment of Assignor's Interest Dec 13, 2016
From: CAMBREX KARLSKOGA AB
To: CAMBREX CHARLES CITY, INC.
Reel/Frame 040723/0170 →
Assignment of Assignor's Interest Dec 14, 2016
From: MOORE, JOSEPH A; BECK, BRENT C
To: SCYNEXIS, INC.
Reel/Frame 040933/0601 →
Change of Name Dec 14, 2016
From: ACCURATUS LAB SERVICES, INC.
To: AVISTA PHARMA SOLUTIONS, INC.
Reel/Frame 040933/0659 →
Assignment of Assignor's Interest Dec 14, 2016
From: LIU, HAO; SLIGAR, JESSICA M; SPEAKE, JASON D
To: SCYNEXIS, INC.
Reel/Frame 040730/0599 →
Assignment of Assignor's Interest Dec 14, 2016
From: SCYNEXIS, INC.
To: ACCURATUS LAB SERVICES, INC.
Reel/Frame 040730/0622 →
Assignment of Assignor's Interest Jan 25, 2017
From: SPEAKE, JASON D; PERALES, JOE B; FAN, WEIMING; ROLLAND, SOLENE CLARISSE
To: AVISTA PHARMA SOLUTIONS, INC.
Reel/Frame 041078/0575 →
Assignment of Assignor's Interest May 26, 2017
From: TRACEY, MICHAEL ROBERT; DONG, ZHIMING ERIC
To: CAMBREX CHARLES CITY, INC.
Reel/Frame 042515/0640 →
Assignment of Assignor's Interest Apr 12, 2018
From: HOLMBERG, PÄR; TRACEY, MICHAEL ROBERT; DONG, ZHIMING ERIC
To: CAMBREX CHARLES CITY, INC.
Reel/Frame 045521/0588 →
Assignment of Assignor's Interest Oct 2, 2018
From: SPEAKE, JASON D.
To: AVISTA PHARMA SOLUTIONS, INC.
Reel/Frame 047031/0830 →
Security Interest Jan 3, 2019
From: CAMBREX CHARLES CITY, INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 047895/0053 →
Security Interest Feb 1, 2019
From: AVISTA PHARMA SOLUTIONS, INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 048218/0762 →
First Lien Patent Security Agreement Dec 4, 2019
From: AVISTA PHARMA SOLUTIONS, INC.; CAMBREX CHARLES CITY, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 051283/0877 →
Notice of Release of Security Interest in Patents Dec 4, 2019
From: WELLS FARGO BANK, NATIONAL ASSOCIATION
To: CAMBREX CHARLES CITY, INC.
Reel/Frame 051283/0903 →
Notice of Release of Security Interest in Patents Dec 4, 2019
From: WELLS FARGO BANK, NATIONAL ASSOCIATION
To: AVISTA PHARMA SOLUTIONS, INC.
Reel/Frame 051196/0092 →
Second Lien Patent Security Agreement Dec 4, 2019
From: CAMBREX CHARLES CITY, INC.; AVISTA PHARMA SOLUTIONS, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 051196/0080 →
Release of Second Lien Security Interest in Patents Dec 7, 2020
From: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
To: AVISTA PHARMA SOLUTIONS, INC.
Reel/Frame 054630/0307 →
Security Interest Mar 6, 2025
From: CAMBREX CHARLES CITY, INC.
To: ARES AGENT SERVICES, L.P., AS COLLATERAL AGENT
Reel/Frame 070421/0947 →
Security Interest Mar 6, 2025
From: AVISTA PHARMA SOLUTIONS, INC.
To: ARES AGENT SERVICES, L.P., AS COLLATERAL AGENT
Reel/Frame 070421/0835 →